loadpatents
name:-0.02731990814209
name:-0.061745166778564
name:-0.00045990943908691
LUKER; Timothy Jon Patent Filings

LUKER; Timothy Jon

Patent Applications and Registrations

Patent applications and USPTO patent grants for LUKER; Timothy Jon.The latest application filed is for "pharmaceutical product comprising a p38 kinase inhibitor and a second active ingredient".

Company Profile
0.23.22
  • LUKER; Timothy Jon - Loughborough Leicestershire GB
  • Luker; Timothy Jon - Cheshire GB
  • Luker; Timothy Jon - Loughborough GB
  • Luker; Timothy Jon - Leicestershire N/A GB
  • Luker; Timothy Jon - Nottingham GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pharmaceutical Product Comprising A P38 Kinase Inhibitor And A Second Active Ingredient
App 20150141387 - COOPER; Anne Elizabeth ;   et al.
2015-05-21
Pyrazinone Derivatives
App 20150073136 - Brough; Stephen ;   et al.
2015-03-12
Pharmaceutical product comprising a p38 kinase inhibitor and a second active ingredient
Grant 8,969,350 - Cooper , et al. March 3, 2
2015-03-03
Pyrazinone derivatives, pharmaceutically acceptance salts thereof and their uses
Grant 8,889,692 - Brough , et al. November 18, 2
2014-11-18
Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
Grant 8,722,741 - Luker , et al. May 13, 2
2014-05-13
Amphetamine Prodrugs
App 20140073589 - WHOMSLEY; Rhys ;   et al.
2014-03-13
Phenoxyacetic acid derivatives useful for treating respiratory diseases
Grant 8,524,715 - Bonnert , et al. September 3, 2
2013-09-03
Bi-aryl amide compounds as CRTh2 receptor modulators
Grant 8,507,544 - Bonnert , et al. August 13, 2
2013-08-13
Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
Grant 8,415,394 - Luker , et al. April 9, 2
2013-04-09
Pyrazinone Derivatives, Pharmaceutically Acceptable Salts Thereof And Their Uses
App 20130012523 - Brough; Stephen ;   et al.
2013-01-10
Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
Grant 8,349,897 - Luker , et al. January 8, 2
2013-01-08
N-cyclopropyl-3-fluoro-5-[3-[[1-[2-[2- [(2-hydroxethyl)amino] ethoxy]phenyl] cyclopropyl] amino]-2-oxo-1 (2H)-pyrazinyl]-4-methyl-benzamide, or pharmaceutically acceptable salts thereof and their uses
Grant 8,299,246 - Brough , et al. October 30, 2
2012-10-30
N-cyclopropyl-3-fluoro-5-[3-[[1-[2-[2- [(2-hydroxethyl)amino] Ethoxy]phenyl] Cyclopropyl] Amino]-2-oxo- 1 (2h)-pyrazinyl]-4-methyl-benzamide, Or Pharmaceutically Acceptable Salts Thereof And Their Uses
App 20120214822 - Brough; Stephen ;   et al.
2012-08-23
Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease
App 20120178814 - Luker; Timothy Jon ;   et al.
2012-07-12
Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease
App 20120178732 - Luker; Timothy Jon ;   et al.
2012-07-12
Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
Grant 8,163,727 - Luker , et al. April 24, 2
2012-04-24
Compounds and their uses 708
Grant 8,163,905 - Brough , et al. April 24, 2
2012-04-24
Compounds
Grant 8,148,572 - Luker , et al. April 3, 2
2012-04-03
Compounds And Their Uses 708
App 20120065214 - BROUGH; Stephen ;   et al.
2012-03-15
Substituted acids for the treatment of respiratory diseases
Grant 8,022,248 - Bonnert , et al. September 20, 2
2011-09-20
Isoquinolinone derivatives
Grant 8,012,980 - Brough , et al. September 6, 2
2011-09-06
Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
Grant 8,008,350 - Luker , et al. August 30, 2
2011-08-30
Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease
App 20110152374 - Luker; Timothy Jon ;   et al.
2011-06-23
Novel Compounds
App 20100311797 - Bonnert; Roger Victor ;   et al.
2010-12-09
Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease
App 20100160285 - Luker; Timothy Jon ;   et al.
2010-06-24
Bi-aryl or aryl-heteroaryl substituted indoles
Grant 7,741,360 - Bonnert , et al. June 22, 2
2010-06-22
Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
Grant 7,737,135 - Luker , et al. June 15, 2
2010-06-15
Substituted indole derivatives for pharmaceutical compositions for treating respiratory diseases
Grant 7,709,521 - Bonnert , et al. May 4, 2
2010-05-04
Isoquinolinone Derivatives
App 20100099665 - BROUGH; Stephen John ;   et al.
2010-04-22
Novel Compounds
App 20090192163 - Luker; Timothy Jon ;   et al.
2009-07-30
Phenoxyacetic Acid Derivatives Useful for Treating Respiratory Diseases
App 20090149448 - Alcaraz; Lilian ;   et al.
2009-06-11
Bi-Aryl or Aryl-Heteroaryl Substituted Indoles
App 20090143449 - Bonnert; Roger Victor ;   et al.
2009-06-04
Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease
App 20090036535 - Luker; Timothy Jon ;   et al.
2009-02-05
Novel Compounds 951
App 20090012151 - Bonnert; Roger Victor ;   et al.
2009-01-08
Substituted Diphenylethers, -Amines, -Sulfides and -Methanes for the Treatment of Respiratory Disease
App 20080293775 - Bonnert; Roger Victor ;   et al.
2008-11-27
Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease
App 20080132480 - Luker; Timothy Jon ;   et al.
2008-06-05
Substituted Acids for the Treatment of Respiratory Diseases
App 20080114002 - Bonnert; Roger Victor ;   et al.
2008-05-15
Modulators of Crth-2 Receptor Activity for the Treatment of Prostaglandin D2 Mediated Diseases
App 20070249686 - Bonnert; Roger Victor ;   et al.
2007-10-25
Substituted indole derivatives for pharmaceutical compositions for treating respiratory diseases
App 20060264444 - Bonnert; Roger Victor ;   et al.
2006-11-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed